NCT03703440Completed
Group Education Trial to Improve Transition in Type 1 Diabetes
Evaluation of a Group Education Program to Improve the Transition From Pediatric to Adult Care for Emerging Adults With Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 21 Nov 2024
Brief summary (registry, in English)
The investigators will conduct a randomized controlled trial (RCT) to examine group education visits as an innovative and potentially cost-effective approach to transition care delivery, that can be easily integrated into usual diabetes care. Among emerging adults with type 1 diabetes (T1D), the investigators aim to assess the effect of group education visits integrated into pediatric care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures after the transfer to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority Randomized Controlled Trial (RCT) of adolescents with T1D (17 years of age) followed at one of the two university teaching hospital-based pediatric diabetes clinics in Montreal. Interventions will occur over 12-months. Follow-up will be to 24 months from enrollment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 212 (actual)
- First submitted
- 9 Oct 2018
- Start date
- 19 Nov 2019
- Primary completion date
- 17 Jul 2024
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Diseases
- Type 1 diabetes
- NCT number
- NCT03703440
What you commit to
- Study type: Interventional
- Participants enrolled: 212
- From 19 Nov 2019 to the primary completion date, 17 Jul 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
Other
- Severe neurocognitive disabilities that may preclude patient's ability to participate in a group education visit
Who the study is looking for
- Adolescents with a diagnosis of Type 1 Diabetes
- 16 to 17 years of age
- Receiving diabetes care at one of two university teaching hospital-based pediatric diabetes clinics in Montreal: Montreal Children's Hospital (MCH) or Centre Hospitalier Universitaire Sainte Justine (CHUSJ)
- Fluent in English or French
Age in the registry: 16 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Universitaire Sainte-Justine (CHUSJ) Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
| Montreal Children's Hospital - McGill University Health Centre (MUHC) Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.